ADMT · XBRL financial data
Adm Tronics Unlimited financial statements, every fiscal year
The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (ADMT's year ends in late March)
| In thousands of dollars | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | Mar 31, 2025 | Mar 31, 2026 |
|---|---|---|---|---|---|---|
| Cost of goods and services sold | 1,929 | 1,958 | 2,019 | 1,849 | 1,801 | 1,992 |
| Gross profit | 1,162 | 1,249 | 1,658 | 1,116 | 1,396 | 1,355 |
| Research and development | 656 | 616 | 541 | 577 | 517 | 545 |
| Selling, general and administrative | 1,049 | 1,674 | 1,086 | 1,359 | 972 | 970 |
| Total operating expenses | 1,842 | 2,378 | 1,628 | 1,936 | 1,490 | 1,515 |
| Operating income (loss) | (680) | (1,129) | 30 | (820) | (94) | (159) |
| Interest income | 15 | 3 | 13 | 25 | 13 | 8 |
| Interest expense | 10 | 16 | 19 | 28 | 40 | 37 |
| Income tax expense (benefit) | (68) | 936 | 121 | 0 | 2 | 2 |
| Net income (loss) | (598) | (1,384) | (96) | (877) | (123) | (100) |
| Earnings per share, basic USD per share | (0.01) | (0.02) | 0.00 | (0.01) | 0.00 | 0.00 |
| Earnings per share, diluted USD per share | — | — | — | — | 0.00 | 0.00 |
| Weighted average shares, basic thousands of shares | 67,588 | 67,588 | 67,588 | 67,588 | 67,588 | 67,588 |
| Weighted average shares, diluted thousands of shares | 67,588 | — | — | — | — | — |
Balance sheet
CSVFiscal years (ADMT's year ends in late March)
| In thousands of dollars | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | Mar 31, 2025 | Mar 31, 2026 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 1,547 | 1,038 | 1,004 | 537 | 383 | 256 |
| Accounts receivable | 1,154 | 730 | — | 345 | 528 | 516 |
| Inventory | 227 | 288 | 443 | 313 | 336 | 251 |
| Prepaid and other current assets | 47 | 58 | 41 | 19 | 2 | 0 |
| Total current assets | 2,975 | 2,114 | 1,986 | 1,214 | 1,249 | 1,022 |
| Property and equipment, net | 22 | 0 | 0 | — | — | — |
| Right-of-use asset | 595 | 513 | 482 | 400 | 313 | 222 |
| Total assets | 5,214 | 3,251 | 3,090 | 2,139 | 2,128 | 1,827 |
| Accounts payable | 364 | 330 | 323 | 266 | 299 | 251 |
| Accrued liabilities | 130 | 133 | 76 | 61 | 29 | 54 |
| Total current liabilities | 1,464 | 1,374 | 1,114 | 1,124 | 1,149 | 1,046 |
| Lease liability, non-current | — | 491 | 410 | 322 | 228 | 130 |
| Total liabilities | 2,456 | 1,877 | 1,524 | 1,446 | 1,457 | 1,256 |
| Accumulated deficit | (30,587) | (31,972) | (32,068) | (32,945) | (32,970) | (33,071) |
| Total stockholders' equity | 2,758 | 1,374 | 1,565 | 692 | 671 | 571 |
| Total liabilities and equity | 5,214 | 3,251 | 3,090 | 2,139 | 2,128 | 1,827 |
| Common shares outstanding (cover page) thousands of shares | 67,588 | 67,588 | 67,588 | 67,588 | 67,588 | 67,588 |
Cash flows
CSVFiscal years (ADMT's year ends in late March)
| In thousands of dollars | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | Mar 31, 2025 | Mar 31, 2026 |
|---|---|---|---|---|---|---|
| Net income (loss) | (598) | (1,384) | (96) | (877) | (123) | (100) |
| Stock-based compensation | 18 | 0 | 69 | 4 | 4 | 0 |
| Depreciation and amortization | 150 | 107 | 3 | 5 | 7 | 7 |
| Net cash from operating activities | (770) | (575) | 125 | (710) | 10 | (124) |
| Net cash from investing activities | — | — | 0 | (15) | (226) | 0 |
| Net cash from financing activities | 878 | 66 | (259) | 258 | 62 | (3) |
| Net change in cash | 108 | (508) | (134) | (467) | (154) | (127) |
Compare with peers
SIC 3845 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3845 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Adm Tronics Unlimited | 223 | not reported | (33) | 67.6M | 6.8 quarters | 10-QJun 30, 2026 |
| Sonoma Pharmaceuticals | 5,338 | 6,406 | (649) | 4.8M | 8.2 quarters | 10-QJun 30, 2026 |
| Bone Biologics | 6,088 | not reported | (532)* | 3.4M | 9.8 quarters | 10-QSep 30, 2026 |
| Autonomix Medical | 3,460 | 0 | (3,544) | 971,043 | 1.0 quarters | 10-QJun 30, 2026 |
| ENvue Medical | 1,084 | 239 | (2,691)* | 11.1M | 0.4 quarters | 10-QJun 30, 2026 |
| SeaStar Medical Holding | 6,959 | 615 | (2,994)* | 4.4M | 2.3 quarters | 10-QJun 30, 2026 |
| Tenon Medical | 1,677 | 1,279 | (2,758)* | 667,047 | 0.6 quarters | 10-QJun 30, 2026 |
| Odyssey Health | 122 | not reported | (160)* | 110.2M | 0.8 quarters | 10-KJul 31, 2026 |
| Sintx Technologies | 3,590 | 452 | (2,767)* | 6.7M | 1.3 quarters | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.